Am­gen can close Hori­zon deal by Sep­tem­ber if no rul­ing from courts on FTC suit

Am­gen and Hori­zon’s $28 bil­lion merg­er will be able to close on Sept. 15 if the Fed­er­al Trade Com­mis­sion’s law­suit to block the merg­er hasn’t been re­solved by that time, the biotech gi­ant said in a se­cu­ri­ties fil­ing Thurs­day.

Un­til then, the deal will be blocked from con­sum­ma­tion by court or­der. Am­gen has said pre­vi­ous­ly that it ex­pects the deal to close by the end of the year, and CEO Robert Brad­way has said that he’s “con­fi­dent” the deal will com­plete de­spite the gov­ern­ment’s ob­jec­tions.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN